Back to News

³Ô¹Ï±¬ÁÏ Commercial Cloud to Help Bristol-Myers Squibb Deliver More Efficient and Effective Customer Engagement

Rapid adoption of ³Ô¹Ï±¬ÁÏ Commercial Cloud continues across industry for better multichannel customer engagement and greater commercial efficiency

PHILADELPHIA ¡ª 2017 ³Ô¹Ï±¬ÁÏ Global Commercial & Medical Summit ¡ª May 8, 2017 ¡ª ³Ô¹Ï±¬ÁÏ Systems (NYSE: VEEV) announced today that Bristol-Myers Squibb, a global biopharmaceutical company, will expand its adoption of ³Ô¹Ï±¬ÁÏ Commercial Cloud in key markets outside of the U.S. The company will add ³Ô¹Ï±¬ÁÏ CRM Events Management to better manage field events by streamlining approvals and reducing complexity in the process. Bristol-Myers Squibb will also leverage ³Ô¹Ï±¬ÁÏ CRM Approved Email to support an integrated, tailored customer engagement experience.

Bristol-Myers Squibb is one of 22 life sciences companies that have adopted ³Ô¹Ï±¬ÁÏ CRM Events Management since its release, quickly establishing it as a leading choice for companies to better orchestrate their customer engagement strategies.

¡°Customers continue to turn to ³Ô¹Ï±¬ÁÏ for a unified suite of applications and data that deliver an orchestrated customer experience,¡± said Peter Gassner, founder and CEO of ³Ô¹Ï±¬ÁÏ. ¡°We¡¯re excited to expand our relationship with Bristol-Myers Squibb and for the opportunity to further support the company¡¯s mission to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.¡±

³Ô¹Ï±¬ÁÏ Commercial Cloud brings together customer data, compliant content, and multichannel engagement to eliminate commercial complexity and speed time to market. Life sciences companies use ³Ô¹Ï±¬ÁÏ Commercial Cloud to deliver greater agility, better customer engagement, and improved efficiency throughout their commercial operations.

Additional Information

For more on ³Ô¹Ï±¬ÁÏ Commercial Cloud, visit: veeva.com/CommercialCloud
Connect with ³Ô¹Ï±¬ÁÏ on LinkedIn:
Follow @veevasystems on Twitter:
Like ³Ô¹Ï±¬ÁÏ on Facebook:

About ³Ô¹Ï±¬ÁÏ Systems

³Ô¹Ï±¬ÁÏ Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ has more than 500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. ³Ô¹Ï±¬ÁÏ is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com.

Forward-looking Statements

This release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ¡¯s products and services, the results from use of ³Ô¹Ï±¬ÁÏ¡¯s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ¡¯s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ¡¯s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ¡¯s financial results are included under the captions, ¡°Risk Factors¡± and ¡°Management¡¯s Discussion and Analysis of Financial Condition and Results of Operations,¡± in the company¡¯s filing on Form 10-K for the period ended January 31, 2017. This is available on the company¡¯s website at veeva.com under the Investors section and on the SEC¡¯s website at . Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.

###

Contact:
³Ô¹Ï±¬ÁÏ Systems
pr@veeva.com